Keiichi Akahoshi
Tokyo Medical and Dental University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Keiichi Akahoshi.
Asian Journal of Endoscopic Surgery | 2018
Yoshiya Ishikawa; Daisuke Ban; Shuichi Watanabe; Keiichi Akahoshi; Hiroaki Ono; Yusuke Mitsunori; Atsushi Kudo; Shinji Tanaka; Minoru Tanabe
The use of laparoscopic distal pancreatectomy (LDP) is increasing worldwide. It is important for surgeons to predict preoperatively the difficulty and risks of a surgery. However, very few reports have evaluated the impact of patient or tumor factors on the difficulty of LDP. We aimed to determine the predictors of technical difficulties when performing LDP.
Journal of Hepato-biliary-pancreatic Sciences | 2016
Atsushi Oba; Daisuke Ban; Susumu Kirimura; Keiichi Akahoshi; Yusuke Mitsunori; Satoshi Matsumura; Takanori Ochiai; Atsushi Kudo; Shinji Tanaka; Tanabe Minoru
For the establishment of personalized therapy, we investigated biomarkers that can contribute to the selection of adjuvant therapy for pancreatic ductal adenocarcinoma (PDAC).
Journal of Gastroenterology and Hepatology | 2018
Keiichi Akahoshi; Daisuke Ban; Ryo Kuboki; Atsushi Oba; Hiroaki Ono; Yusuke Mitsunori; Atsushi Kudo; Shinji Tanaka; Minoru Tanabe
To improve the prognosis of cholangiocarcinoma, we investigated potential biomarkers that may enable the selection of patients for whom postoperative adjuvant chemotherapy is likely effective.
Annals of Gastroenterological Surgery | 2018
Daisuke Ban; Toshiro Ogura; Keiichi Akahoshi; Minoru Tanabe
Treatment strategy for hepatocellular carcinoma (HCC) requires optimal selection of therapies based on various factors related to tumor condition and liver functional reserve. Although several evidence‐based guidelines have been proposed for the treatment of HCC, the criteria and range of indications differ among these guidelines according to the circumstances of each country. In European nations and the USA, patients with the Barcelona Clinic Liver Cancer stage 0‐A are subjects for surgical resection, whereas in Asian countries, even those with the intermediate stage are regarded as surgical candidates. Furthermore, since the recent introduction and rapidly widely spreading use of laparoscopic liver resection, this technique has become an important treatment option for surgical resection. In this review article, we overview the current topics of treatment of HCC with a special focus on surgical therapy.
Journal of Gastroenterology | 2016
Keiichi Akahoshi; Shinji Tanaka; Kaoru Mogushi; Shu Shimada; Satoshi Matsumura; Yoshimitsu Akiyama; Arihiro Aihara; Yusuke Mitsunori; Daisuke Ban; Takanori Ochiai; Atsushi Kudo; Shigeki Arii; Minoru Tanabe
Archive | 2018
Yoshiya Ishikawa; Daisuke Ban; Shuichi Watanabe; Keiichi Akahoshi; Hiroaki Ono; Yusuke Mitsunori; Atsushi Kudo; Shinji Tanaka; Minoru Tanabe
Journal of Surgical Research | 2018
Keiichi Akahoshi; Hiroaki Ono; Masafumi Akasu; Daisuke Ban; Atsushi Kudo; Atsuko Konta; Shinji Tanaka; Minoru Tanabe
Journal of Cancer Research and Clinical Oncology | 2018
Yuki Mizuno; Atsushi Kudo; Takumi Akashi; Keiichi Akahoshi; Toshiro Ogura; Kosuke Ogawa; Hiroaki Ono; Yusuke Mitsunori; Daisuke Ban; Shinji Tanaka; Ukihide Tateishi; Minoru Tanabe
Annals of Surgery | 2018
Atsushi Kudo; Keiichi Akahoshi; Sakiko Ito; Takumi Akashi; Shu Shimada; Toshiro Ogura; Kosuke Ogawa; Hiroaki Ono; Yusuke Mitsunori; Daisuke Ban; Ukihide Tateishi; Shinji Tanaka; Minoru Tanabe
American Journal of Pathology | 2018
Norimichi Chiyonobu; Shu Shimada; Yoshimitsu Akiyama; Kaoru Mogushi; Michiko Itoh; Keiichi Akahoshi; Satoshi Matsumura; Kosuke Ogawa; Hiroaki Ono; Yusuke Mitsunori; Daisuke Ban; Atsushi Kudo; Shigeki Arii; Takayoshi Suganami; Shoji Yamaoka; Yoshihiro Ogawa; Minoru Tanabe; Shinji Tanaka